Brief: Glenmark Pharma Launches Vancomycin Hydrochloride For Injection USP, 500 Mg/Vial And 1 G/Vial
18/05/2026 04:28
May 18 (Reuters) - Glenmark Pharmaceuticals Ltd GLEN.NS: GLENMARK PHARMA - LAUNCHES VANCOMYCIN HYDROCHLORIDE FOR INJECTION USP, 500 MG/VIAL AND 1 G/VIAL Source text: ID:nBSE93bDRP Further company coverage: GLEN.NS ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Glenmark Pharmaceuticals
See all newsBrief: Glenmark Pharma Says Glenmark Pharmaceuticals Inc Usa Launches Methylene Blue Injection Usp, 50 Mg/10 Ml Single-Dose Vial
Brief: Glenmark Pharma Launches Winlevi 10 Mg/G Cream In Key European Markets
Brief: Glenmark Pharma Says Glenmark Pharmaceuticals USA Launches Lacosamide Injection USP
Brief: Glenmark Pharma Approves Transfer Of Nebulizer Brands/Ip Portfolio To Unit
Brief: Glenmark Pharma Q4 Consol Net Profit 3.01 Billion Rupees